Skip to main content

Azelastine

Generic: Azelastine

Verified·Apr 23, 2026
NDC
58602-020
RxCUI
1797867
Route
NASAL
ICD-10 indication
J30.1

Affordability Check

How much will you actually pay for Azelastine?

In 30 seconds, see every legitimate way to afford Azelastine — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Azelastine

What is this medication?

Azelastine is a prescription antihistamine medication primarily used to manage symptoms caused by seasonal or year-round allergies. When utilized as a nasal spray, it is effective at reducing sneezing, an itchy or runny nose, and nasal congestion associated with allergic rhinitis. Furthermore, this medication is prescribed for vasomotor rhinitis, a condition where people experience allergy-like symptoms that are actually caused by non-allergic triggers such as changes in weather or exposure to smoke.

The medication is also available in the form of eye drops, which are specifically designed to alleviate itching and redness caused by allergic conjunctivitis. Azelastine functions by blocking the effects of histamine, which is a chemical the body releases during an allergic reaction. By inhibiting histamine activity, the medication helps to control the inflammatory response in the nose or eyes, allowing patients to find relief from their allergy triggers and improve their daily comfort.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Azelastine. Official source: DailyMed (NLM) · Label effective Dec 15, 2025

Indications and usage
Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: ■ nasal congestion ■ runny nose ■ sneezing ■ itchy nose
Dosage and administration
Directions ■ Read the User Guide for how to: ■ prime the bottle before first use ■ use the spray ■ prime bottle again if not used for 3 or more days ■ clean the spray nozzle if it gets clogged adults and children 12 years and older This product may be used either once or twice a day: ■ once daily: use 2 sprays in each nostril; OR ■ twice daily: use 1 or 2 sprays in each nostril every 12 hours ■ do not use more than 4 sprays in each nostril in a 24 hour period children 6 years to 11 years ■ an adult should supervise use ■ 1 spray in each nostril every 12 hours ■ do not use more than 2 sprays in each nostril in a 24 hour period children under 6 years do not use
Warnings
Warnings Only for use in the nose. Do not spray in eyes or mouth.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Azelastine appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

48%

2,640 of 5,509 plans

Most common tier

Tier 2

On 46% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)95
29%
Tier 2 (generic)151
46%
Tier 3 (preferred brand)69
21%
Tier 4 (non-preferred brand)14
4%

Step therapy: 0% of formularies

Quantity limits: 1% of formularies

Coverage breadth: 329 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.